Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded encouraging insights into new therapeutic approaches. Current efforts centers on modifying the underlying pathophysiology of MSA. One strategy under investigation involves drug-based interventions to regulate the dysregulation of s